Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Jump to content

Butallylonal: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: ChEMBL.
 
(16 intermediate revisions by 14 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox | verifiedrevid = 399698007
{{Drugbox
|
| Watchedfields = changed
| IUPAC_name = 5-''sec''-Butyl-5-(beta-bromoallyl)barbituric acid
| verifiedrevid = 414038144
| image = Butallylonal structure.svg
| IUPAC_name = 5-''sec''-Butyl-5-(beta-bromoallyl)barbituric acid
| width = 155
| image = Butallylonal structure.svg
| width = 155

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule IV
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1142-70-7
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = H223WHY93B
| ATC_prefix = none
| ATC_suffix =
| PubChem = 14362
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13723
| ChemSpiderID = 13723
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| InChI = 1/C11H15BrN2O3/c1-4-6(2)11(5-7(3)12)8(15)13-10(17)14-9(11)16/h6H,3-5H2,1-2H3,(H2,13,14,15,16,17)
| smiles = O=C1NC(=O)NC(=O)C1(C(C)CC)CC(\Br)=C
| InChIKey = FWZMBTIUIQUJFF-UHFFFAOYAI
| ChEMBL = 469253
| ChEMBL = 469253

<!--Chemical data-->
| C=11 | H=15 | Br=1 | N=2 | O=3
| smiles = O=C1NC(=O)NC(=O)C1(C(C)CC)CC(\Br)=C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H15BrN2O3/c1-4-6(2)11(5-7(3)12)8(15)13-10(17)14-9(11)16/h6H,3-5H2,1-2H3,(H2,13,14,15,16,17)
| StdInChI = 1S/C11H15BrN2O3/c1-4-6(2)11(5-7(3)12)8(15)13-10(17)14-9(11)16/h6H,3-5H2,1-2H3,(H2,13,14,15,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FWZMBTIUIQUJFF-UHFFFAOYSA-N
| StdInChIKey = FWZMBTIUIQUJFF-UHFFFAOYSA-N
| CAS_number = 1142-70-7
| ATC_prefix = none
| ATC_suffix =
| PubChem = 14362
| DrugBank =
| C=11|H=15|Br=1|N=2|O=3
| molecular_weight = 303.15 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}}
}}


'''Butallylonal''' is a [[barbiturate]] derivative invented in the 1920s.<ref>{{cite patent|country=US|number=1739662}}</ref> It has [[sedative]] properties, and was used primarily as an anaesthetic in [[veterinary]] medicine.<ref>{{cite journal | doi = 10.1007/BF01907782 | author = Mittmann U, Schmidt HD, Schmier J, Wirth RH | title = Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models | journal = Basic Research in Cardiology | year = 1976 | volume = 71 | issue = 1 | pages = 47–59 | pmid = 1259685}}</ref> Butallylonal is considered similar in effects to [[pentobarbital]] but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.
'''Butallylonal''' is a [[barbiturate]] derivative invented in the 1920s.<ref>{{cite patent|country=US|number=1739662}}</ref> It has [[sedative]] properties, and was used primarily as an anaesthetic in [[veterinary]] medicine.<ref>{{cite journal | doi = 10.1007/BF01907782 | vauthors = Mittmann U, Schmidt HD, Schmier J, Wirth RH | title = Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models | journal = Basic Research in Cardiology | year = 1976 | volume = 71 | issue = 1 | pages = 47–59 | pmid = 1259685| s2cid = 5567045 }}</ref> Butallylonal is considered similar in effects to [[pentobarbital]] but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.


== References ==
== References ==
{{reflist}}
{{reflist}}


{{barbiturates}}
{{GABAAR PAMs}}

{{pharma-stub}}



[[Category:Barbiturates]]
[[Category:Barbiturates]]
[[Category:Organobromides]]
[[Category:Organobromides]]
[[Category:Alkenes]]
[[Category:Alkene derivatives]]
{{sedative-stub}}

[[de:Butallylonal]]